IntelyCare Valuation, Funding & Investors

IntelyCare is valued at $1.1B as of April 2022.

Last IntelyCare valuation

$1.1B

Series C · Apr 2022

Last IntelyCare funding round

$115M

Series C · Apr 2022

Cumulative funding IntelyCare raised

$171M

across 3 funding rounds

Key investors in IntelyCare

  • Kaiser Permanente Ventures
  • Revelation Partners
  • Endeavour Vision
  • Janus Henderson
  • Longitude Capital
  • Eastward Capital Partners

IntelyCare Overview

About IntelyCare

IntelyCare is a Boston-headquartered platform founded in 2014 that matches licensed nurses and nursing assistants with per diem shifts at post-acute care facilities across the United States. The company leverages a mobile app and predictive analytics to fill shifts three times faster than industry averages, serving over 1,000 facilities in 25 states. IntelyCare's tools forecast staffing needs, optimize schedules, and provide real-time shift updates, helping providers manage labor shortages while offering nurses flexible work options with transparent pay rates.


Founded

2014

HQ

United StatesBoston, MA

Status

Privately held

Customer focus

B2B

Revenue model

Commission, Subscription

Valuation

$1.1B (Apr 2022)

IntelyCare Valuation

IntelyCare is currently valued at $1.1B, based on its Series C in April 2022.

The $115M round was led by Janus Henderson, with participation from Revelation Partners, Kaiser Permanente Ventures, Leeds Illuminate, Endeavour Vision and Longitude Capital.

IntelyCare valuation by funding round

IntelyCare valuation by funding round
DateStageValuation
Apr 2022Series C$1.1B

IntelyCare Funding History

IntelyCare has raised a total of $171M across 3 funding rounds.

IntelyCare's first fundraising round was a $11M Series A in November 2018. The most recent completed round was a $115M Series C in April 2022.

IntelyCare funding rounds

IntelyCare funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Apr 2022Series CJanus Henderson (lead); Revelation Partners; Kaiser Permanente Ventures; Leeds Illuminate; Endeavour Vision; Longitude Capital$115M$1.1BIntelyCare is a cloud-based healthcare workforce management platform that uses machine learning and artificial intelligence to match nursing professionals with healthcare facilities, helping predict and flexibly manage staffing needs. The company operates a gig-model-based approach that provides nurses with flexible scheduling control while enabling healthcare facilities to better manage their internal and per diem staff across their operations. On April 6, 2022, IntelyCare completed a Series C funding round of $115 million led by Janus Henderson Investors and including Endeavour Vision, Kaiser Permanente Ventures, Leeds Illuminate, Longitude Capital, and Revelation Partners. The round valued the company at $1.1 billion post-money valuation. At the time of the funding, IntelyCare had achieved substantial growth, more than tripling its revenue in 2021 and growing annual revenue by over 850% since its $45 million Series B round in early 2020. Estimated annual recurring revenue (ARR) as of 2022 was approximately $545.8 million, reflecting the company's rapid scaling. The company had expanded to operate across 28 states with over 30,000 nursing professionals on its platform serving more than 1,600 healthcare facilities nationwide. The Series C capital was designated for expansion into new U.S. states and investment in IntelyCare's artificial intelligence and data analytics capabilities, as the company continued to establish itself as the largest tech-enabled nurse staffing platform in the United States.
Feb 2020Series BEndeavour Vision (lead); Revelation Partners; Kaiser Permanente Ventures; Generator Ventures$45M-IntelyCare is a Boston-based digital workforce augmentation platform that applies gig economics and advanced data science to match nurses with post-acute care facilities, filling shifts at three times the industry average and optimizing staffing needs. The company raised $45 million in its Series B round on February 20, 2020, led by Endeavour Vision with participation from Kaiser Permanente Ventures and Generator Ventures, alongside existing investors like Revelation Partners. This marked the largest venture round in nursing technology at the time, comprising new equity and debt financing to expand the platform, enhance data analytics, acquire clients, and address the projected 1 million nurse shortfall by 2030. At the time of the Series B, IntelyCare's platform served over 400 facilities and 11,000 nurses, staffing 2 million hours of care gaps. The company had doubled its revenue and facility count from 2018 to 2019, demonstrating rapid growth. Post-Series B, IntelyCare continued scaling, raising a $115 million Series C in April 2022 led by Janus Henderson Investors at a $1.1 billion valuation, with returning investors including Endeavour Vision, Revelation Partners, and Kaiser Permanente Ventures. Annual revenue grew over 850% since the 2020 round, nurse pool doubled in 2021, and client demand nearly tripled, expanding to over 30,000 nurses and 1,600 facilities across multiple states. Total funding reached $174 million across rounds.
Nov 2018Series ALeerink Revelation Partners (lead); Longmeadow Capital Partners; LRVHealth; Eastward Capital Partners$11M-IntelyCare raised $10.8 million in its Series A funding round in November 2018, led by Leerink Revelation Partners with participation from Longmeadow Capital Partners, LRVHealth, and angel investor Bill Mantzoukas. This brought the company's total funding to $14 million following a prior seed round. The platform provides intelligent workforce management software for post-acute care facilities, matching nurses and certified nursing assistants with flexible shifts to address staffing shortages. The funding supported accelerated product development and market adoption of IntelyCare’s on-demand nurse staffing app. IntelyCare aims to streamline administration, reduce burnout, and improve patient care by better allocating nursing professionals. The company had previously raised approximately $3 million in seed funding in 2017.

Who has invested in IntelyCare?

11 investors have backed IntelyCare across its funding rounds, including Kaiser Permanente Ventures, Revelation Partners, Endeavour Vision, Janus Henderson, Longitude Capital and Eastward Capital Partners.

Lead investors include Janus Henderson, Endeavour Vision and Leerink Revelation Partners.


IntelyCare Investors

Investors in IntelyCare by funding rounds participated
InvestorHQRoundsRoleFirst check
Revelation PartnersUnited StatesSan Francisco, CA2ParticipantFeb 2020
Kaiser Permanente VenturesUnited StatesSan Francisco, CA2ParticipantFeb 2020
Endeavour VisionSwitzerlandGeneva2LeadFeb 2020
Leerink Revelation PartnersUnited StatesUnited States1LeadNov 2018
Janus HendersonUnited StatesLondon1LeadApr 2022
Longmeadow Capital PartnersUnited StatesStamford, CT1ParticipantNov 2018
LRVHealthUnited StatesBoston, MA1ParticipantNov 2018
Leeds IlluminateUnited StatesChapel Hill, NC1ParticipantApr 2022
Generator VenturesUnited StatesSan Francisco, CA1ParticipantFeb 2020

This data is available for Pro users. Sign up to see all 11 IntelyCare investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by IntelyCare

IntelyCare has acquired 1 company to date.

Last acquisition by IntelyCare was on January 8th 2026. IntelyCare acquired CareRev for undisclosed valuation.


Latest Acquisitions by IntelyCare

CareRev
Description
CareRev is a Los Angeles-headquartered online marketplace connecting hospitals and outpatient facilities with per diem healthcare professionals across the United States. The platform enables direct booking of nurses, therapists, and technicians for shifts, bypassing agencies to reduce costs and fill rates. Operating in over 20 states, it maintains nurse-to-patient ratios and enhances staffing flexibility for facilities nationwide.
HQ CountryUnited States
HQ City
Los Angeles, CA
Deal Date8 Jan 2026
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all IntelyCare acquisitions and their M&A valuation multiples.

Start Free Trial

IntelyCare Competitors

IntelyCare competitors include listed companies like U.S. Physical Therapy and SMS, and private ones like NexHealth, Helian Health, United Imaging Intelligence and Collective Health.

Public and private companies comparable to IntelyCare
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
NexHealthUnited StatesSan Francisco, CAPrivate--$1B-
U.S. Physical TherapyUnited StatesUnited StatesPublicly listed$781M$110M$1.2B2.3x
Helian HealthChinaHangzhouPrivate--$900M-
United Imaging IntelligenceChinaShanghaiPrivate--$1.4B-
SMSJapanJapanPublicly listed$416M($63M)$1.4B3.2x
Collective HealthUnited StatesSan Francisco, CAPrivate--$1.5B-

IntelyCare Public Comps

IntelyCare is still privately-owned, but its public comps include PHC Holdings, FESCO Group, Zensar Technologies, Vitec Software, iFLYHealth, BLS International, McMillan Shakespeare, U.S. Physical Therapy, TKC and HealthStream.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
PHC Holdings$2.3B$320M1.0x1.0x7.2x6.5x
FESCO Group$6.7B$296M0.0x0.0x0.5x0.7x
Zensar Technologies$593M$105M1.3x1.3x7.5x8.1x
Vitec Software$371M$151M3.7x3.5x9.1x9.0x
iFLYHealth$136M($7M)7.7x6.2x(150.8x)(144172.5x)
BLS International$313M$89M2.9x2.6x10.0x9.4x
McMillan Shakespeare$336M$179M4.5x3.5x8.4x11.4x
U.S. Physical Therapy$781M$110M2.5x2.3x17.5x18.9x

This data is available for Pro users. Sign up to see all IntelyCare competitors and their valuation data.

Start Free Trial

Common questions about IntelyCare

When was IntelyCare founded?IntelyCare was founded in 2014.
Where is IntelyCare headquartered?IntelyCare is headquartered in Boston, MA, United States.
Is IntelyCare publicly listed?No, IntelyCare is a private, VC-backed company.
What is IntelyCare's valuation?IntelyCare was last valued at $1.1B in its Series C in April 2022.
How much funding has IntelyCare raised?IntelyCare has raised $171M across 3 funding rounds.
What was IntelyCare's last funding round?IntelyCare's last funding round was a $115M Series C in April 2022, led by Janus Henderson.
Who are IntelyCare's investors?IntelyCare's investors include Revelation Partners, Kaiser Permanente Ventures, Endeavour Vision, Leerink Revelation Partners, Janus Henderson, Longmeadow Capital Partners, LRVHealth, Leeds Illuminate, Generator Ventures, Eastward Capital Partners and 1 other.
Which companies are comparable to IntelyCare?Companies comparable to IntelyCare include NexHealth, U.S. Physical Therapy, Helian Health, United Imaging Intelligence, SMS and Collective Health.
How many companies has IntelyCare acquired?IntelyCare has acquired 1 company, including CareRev.

See companies similar to IntelyCare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial